Targeting cadherin-6 (CDH6) with an antibody-drug conjugate for the treatment of ovarian and renal cancer

被引：1
|
作者：
Collins, Scott D.
Saxena, Parmita
Li, Xiao Y.
Shim, Yeonju
Ostrom, Lance
Yoder, Nicholas C.
Catcott, Kalli C.
McShea, Molly A.
Sun, Xiuxia
Bilic, Sanela
Tschantz, William R.
Flaherty, Meghan
Mansfield, Keith
Hu, Tiancen
Capka, Vladimir
Kurz, Markus
Rajlic, Ivana Liric
London, Anne Serdakowski
Duc Nguyen
Mosher, Rebecca
Meyer, Matthew J.
Bourret, Aaron
Saeh, Jamal
Cameron, Scott
Lees, Emma
Bialucha, Carl U.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2974
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2974
引用
收藏
页数：4
相关论文
共 50 条
  • [41] DS-6000a, a novel CDH6-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Suzuki, H.
    Nagase, S.
    Saito, C.
    Nagata, M.
    Kaneda, Y.
    Honda, K.
    Nishiya, Y.
    Honda, T.
    Nakada, T.
    Goto, R.
    Ishizaka, T.
    Myobatake, Y.
    Abe, Y.
    Agatsuma, T.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S363 - S364
  • [42] ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment
    Lamberts, Laetitia E.
    van Oordt, Catharina W. Menke-van der Houven
    ter Weele, Eva J.
    Bensch, Frederike
    Smeenk, Michiel M.
    Voortman, Johannes
    Hoekstra, Otto S.
    Williams, Simon P.
    Fine, Bernard M.
    Maslyar, Daniel
    de Jong, Johan R.
    Gietema, Jourik A.
    Schroder, Carolien P.
    Bongaerts, Alphons H. H.
    Lub-de Hooge, Marjolijn N.
    Verheul, Henk M. W.
    Bohorquez, Sandra M. Sanabria
    Glaudemans, Andor W. J. M.
    de Vries, Elisabeth G. E.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1642 - 1652
  • [43] CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer
    Shiomi, Mayu
    Matsuzaki, Shinya
    Serada, Satoshi
    Matsuo, Koji
    Mizuta-Odani, Chihiro
    Jitsumori, Mariko
    Nakae, Ruriko
    Matsuzaki, Satoko
    Nakagawa, Satoshi
    Hiramatsu, Kosuke
    Miyoshi, Ai
    Kobayashi, Eiji
    Kimura, Toshihiro
    Ueda, Yutaka
    Yoshino, Kiyoshi
    Naka, Tetsuji
    Kimura, Tadashi
    [J]. CANCER SCIENCE, 2021, 112 (09) : 3655 - 3668
  • [44] Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1
    Thomas, Lawrence J.
    Vitale, Laura
    O'Neill, Thomas
    Dolnick, Ree Y.
    Wallace, Paul K.
    Minderman, Hans
    Gergel, Lauren E.
    Forsberg, Eric M.
    Boyer, James M.
    Storey, James R.
    Pilsmaker, Catherine D.
    Hammond, Russell A.
    Widger, Jenifer
    Sundarapandiyan, Karuna
    Crocker, Andrea
    Marsh, Henry C., Jr.
    Keler, Tibor
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (12) : 2946 - 2954
  • [45] U3-1402, a Novel HER3-Targeting Antibody-Drug Conjugate, for the Treatment of Colorectal Cancer
    Koganemaru, Shigehiro
    Kuboki, Yasutoshi
    Koga, Yoshikatsu
    Kojima, Takashi
    Yamauchi, Mayumi
    Maeda, Naoyuki
    Kagari, Takashi
    Hirotani, Kenji
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    Doi, Toshihiko
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (11) : 2043 - 2050
  • [46] An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities
    Nicolazzi, Celine
    Caron, Anne
    Tellier, Alexia
    Trombe, Marc
    Pinkas, Jan
    Payne, Gillian
    Carrez, Chantal
    Guerif, Stephane
    Maguin, Marie
    Baffa, Raffaele
    Fassan, Matteo
    Adam, Julien
    Mangatal-Wade, Lydie
    Blanc, Veronique
    [J]. MOLECULAR CANCER THERAPEUTICS, 2020, 19 (08) : 1660 - 1669
  • [47] Preclinical development of a novel camptothecin-based antibody-drug conjugate targeting solid tumors expressing Claudin-6
    Tsang, Nicola
    Veillard, Nicolas
    Horsley, Elizabeth
    Havenith, Karin
    Janghra, Narinder
    Zaitseva, Kristina
    Oblette, Cecile
    Kirby, Ian
    Hogg, Paul W.
    Zammarchi, Francesca
    de Haan, Lolke
    van Berkel, Patrick H.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [48] Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers
    Bialucha, Carl U.
    Collins, Scott D.
    Li, Xiao
    Saxena, Parmita
    Zhang, Xiamei
    Durr, Clemens
    Lafont, Bruno
    Prieur, Pierric
    Shim, Yeonju
    Mosher, Rebecca
    Ostrom, David Lee Lance
    Hu, Tiancen
    Bilic, Sanela
    Rajlic, Ivana Liric
    Capka, Vladimir
    Jiang, Wei
    Wagner, Joel P.
    Elliott, GiNell
    Veloso, Artur
    Piel, Jessica C.
    Flaherty, Meghan M.
    Mansfield, Keith G.
    Meseck, Emily K.
    Rubic-Schneider, Tina
    London, Anne Serdakowski
    Tschantz, William R.
    Kurz, Markus
    Duc Nguyen
    Bourret, Aaron
    Meyer, Matthew J.
    Faris, Jason E.
    Janatpour, Mary J.
    Chan, Vivien W.
    Yoder, Nicholas C.
    Catcott, Kalli C.
    McShea, Molly A.
    Sun, Xiuxia
    Gao, Hui
    Williams, Juliet
    Hofmann, Francesco
    Engelman, Jeffrey A.
    Ettenberg, Seth A.
    Sellers, William R.
    Lees, Emma
    [J]. CANCER DISCOVERY, 2017, 7 (09) : 1030 - 1045
  • [49] Novel CDH17-targeting antibody-drug conjugate exhibits anti-tumor efficacy in preclinical models of gastrointestinal cancers
    Wong, Po Yee
    He, Lin
    Chow, Kronos
    Wong, Kwan Wa
    O, Chui Yee
    Wong, Dennis
    Luk, John Moon
    Lo, Pui-Chi
    Wong, Kwong Fai
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [50] The efficacy and toxicity of mirvetuximab soravtansine, a novel antibody-drug conjugate, in the treatment of advanced or recurrent ovarian cancer: a meta-analysis
    Xu, Ke
    Wang, Tianlei
    Pan, Shenbin
    He, Jie
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (11) : 1141 - 1152
12345